CVRx | Barostim
Avatar

Long-Term Results of the BeAT-HF Clinical Study

By CVRx | Barostim FEATURING JoAnn Lindenfeld
By CVRx | Barostim FEATURING JoAnn Lindenfeld
23 views
April 24, 2024

Dr. Lindenfeld reviews clinical evidence from the post-market phase of the BeAT-HF trial.

0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
10:21
CVRx | Barostim

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov
17:33
CVRx | Barostim

Beyond BeAT-HF: Real World Experience with Barostim

Feat. G. Panjrath
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
11:18
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. G. Panjrath, D. Yaranov, J. Lindenfeld, J. Thomas Heywood
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
10:51
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. M. PEREZ-IZQUIERDO
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
11:18
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. G. Panjrath, D. Yaranov, J. Lindenfeld, J. Thomas Heywood
17:33
CVRx | Barostim

Beyond BeAT-HF: Real World Experience with Barostim

Feat. G. Panjrath
10:21
CVRx | Barostim

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
06:59
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling, M. PEREZ-IZQUIERDO
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
11:59
CVRx | Barostim

Patient Identification to Follow-up And New Implant Approach

Feat. J. Allred
11:23
CVRx | Barostim

Baroreflex Activation Therapy: What Has Real-World Experience Taught…

Feat. J. Bauersachs
11:51
CVRx | Barostim

Unlocking the Potential of Baroreflex Activation Therapy (BAT) for H…

Feat. M. Fudim, J. Bauersachs, W. Abraham
12:31
CVRx | Barostim

Baroreflex Activation Therapy: What Have We Learned From Clinical Tr…

Feat. W. Abraham